{
    "nctId": "NCT02462681",
    "briefTitle": "Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery",
    "officialTitle": "Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Acute Pain, Chronic Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "changes in pain intensity score from baseline",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* all patients scheduled for elective modified radical mastectomy with axillary dissection will be enrolled in the study\n\nExclusion Criteria:\n\n* patients with a known allergy to the study drugs\n* patients with bleeding diathesis\n* patients with infection at the site of injection\n* patients with central neuropathy\n* patients with liver impairment\n* patients with renal impairment\n* drugs or alcohol abusers\n* patients with psychiatric illnesses",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}